Ziverdox is a combination therapy including Zinc, Ivermectin, and Doxycycline, that was developed by Topelia Therapeutics to treat patients in 

A Phase II Double-Blind Randomized Placebo-Controlled Trial of Combination Therapy to Treat COVID-19 Infection.